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NeuroferritinopathyWe report a healthy adult male, who underwent, as a control subject, part of a Huntington's disease study,
extensive testing during three visits in a two year follow-up, including clinical examination and 3.0 T MRI
scans. The T2-weighted MRI sequences revealed the “eye-of-the-tiger-sign”. No clinical abnormalities in either
motor, cognitive or behavioural domains were observed. PKAN2 and FTL gene mutation analysis were negative.
This ﬁnding implies that an eye-of-the-tiger sign, which is considered a pathognomonic feature of neurodegen-
eration with brain iron accumulation (NBIA), can occur without any clinical symptoms.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The eye-of-the-tiger-sign is known as a radiological sign, that refers to
abnormal low signal intensity in the globus pallidus, with a central longi-
tudinal zone of high signal, as seen on T2-weightedMRI images [1]. In the
transverse plane through the basal ganglia this appears as a tiger like
image with prominent eyes. The sign is considered the distinctive radio-
logic feature of neurodegeneration with brain iron accumulation (NBIA)
type 1, also known as pantothenate kinase associated neurodegeneration
(PKAN), or formerly known as Hallervorden–Spatz disease [2].
Clinically, NBIA is described into two types: the classic disease type
with early onset and rapid progression [2], and the atypical disease
with later onset and slow progression [2,3]. The classic type usually is
apparentwithin the ﬁrst decade of life, while the atypical variant is usu-
ally in the second or third. Clinical features of NBIA are highly variable
and consist of a range of motor symptoms, including chorea, dystonia,
bradykinesia, tremor, gait abnormalities, dysarthria, ataxia and rigidity.
Other features include cognitive impairment, corticospinal tract in-
volvement, optic atrophy and pigmentary retinopathy [4–6].
On a genetic basis, several subtypes of NBIA have been distin-
guished associated with nine different gene mutations [7]. Most
well-known are PKAN with mutations in the PANK2 gene, infantile
neuroaxonal dystrophy (INAD) with mutations in the PLA2G6 gene,
neuroferritinopathy with mutations in the ferritin light chain geneidenUniversityMedical Centre,
71 526 1634/2197; fax:+3171
van den Bogaard).
ights reserved.(FTL1) and aceruloplasminemia withmutations in the ceruloplasmin
gene. However several subtypes have recently been added among
other fatty acid hydroxylase-associated neurodegeneration (FAHN)
with a mutation in the FAH2 gene, static encephalopathy of child-
hood with neurodegeneration in adulthood (SENDA) with defects
in the WDR45 gene, an X-linked form within the same gene and
mitochondrial membrane protein-associated neurodegeneration
(MPAN) with mutations in the C19ORF12 gene.
Only the PANK2 and neuroferritinopathy type have been shown to
display the typical eye-of-the-tiger-sign [8]. Although the eye-of-the-
tiger-sign is seen in 100% of the PANK2mutation carriers [8], this radio-
logic ﬁnding has also been described in case reports onmultiple system
atrophy Parkinson variant (MSA-P) [9], progressive supranuclear palsy
(PSP) [10] and corticobasal degeneration (CBD) [11]. We are not aware
of earlier studies describing the eye-of-the-tiger-sign in healthy adults.
2. Patient and methods
2.1. Case
Our case is a 48-year old male who participated in the TRACK-HD
study, a biomarker study on Huntington's disease [12], as a healthy con-
trol subject. He was recruited as a spouse of a Huntington patient. His
medical history noted no relevant abnormalities. He was not using any
medication. The family history revealed no neurological diseases. On a
thorough screening for psychiatric and cognitive disturbances he re-
ported no complaints of any kind. His vital signs were normal as was
the general physical exam. Extensive neurological testing did not reveal
any abnormalities, especially no chorea, dystonia, bradykinesia or
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HD study, showed no abnormalities and included the Mini Mental
State Exam, Trail Making Test, symbol digit modality test, Stroop test
and verbal ﬂuency. Psychiatric screening included the Beck's depression
inventory (BDI), second version, the problem behaviour assessment
(PBA), the frontal systems behaviour examination (FrSBe) and the hos-
pital anxiety and depression scale (HADS). Further testing included
blood draw and MRI at 3.0 T. For full details on all tests we refer to the
TRACK-HD paper [12]. At 12 and 24months of follow-up all clinical pa-
rameters stayed normal.2.2. Laboratory tests
Venous blood draw, conducted not as part of the TRACK-HD study, on
ferritin was slightly below the normal range, namely 33.13 μg/l, with a
normal range of 35–260 μg/l. Iron content was below the normal
range; 7μmol/l, range 11–28. No other blood abnormalitieswere present.2.3. Genetic analysis
Sequence analysis of PKAN2 and FTL genes revealed nomutations
in either gene. As mutations in the PLA2G6 gene and FAH2 gene
are only associated with early onset disorders (up to the fourth de-
cade) these were not tested. Laboratory testing made the diagnosis
of aceruloplasminemia improbable; hence no gene analysis was
initiated.Fig. 1. T2 spin echo, T2 gradient echo and SWI images displaying the ey2.4. Radiologic examination
2.4.1. MRI parameters
On 3 separate occasions with one year apart, T1- and T2-weighted
images were acquired on a 3.0 T whole body MRI system (Philips
Healthcare, Best, The Netherlands). The protocol consisted of a T1-
weighted 3D ultrafast gradient echo sequence (TR 7.7 ms, TE 3.5 ms,
ﬂip angle 8°, FOV 240mm, matrix 224×224×164mm, slice thickness
1 mm), and a volumetric T2-weighted VISTA gradient echo sequence
(TR 867ms, TE 9.3ms, and same FOV, matrix, and slice thickness).
2.4.2. Interpretation
On the T2 images a bilateral central hyperintense region is visible in
the internal segment of the globus pallidus, which is hypointense on T1
weighted images. Surrounding tissue is hypointense on T2. This image
qualiﬁes as a typical eye-of-the-tiger-sign. Additionally, bilateral small
focal hyperintense regions in the caudal part of the substantia nigra sim-
ilar to those in the globus pallidus are visible, these are of unknown signif-
icance. No other abnormalities in any other region are apparent (Fig. 1).
On follow-up no alterations were seen in the eye-of-the-tiger-sign
(Fig. 1) and the few abnormalities in the substantia nigra were not visible
anymore.
3. Discussion
The ﬁnding of an eye-of-the-tiger sign in a healthy adult on MRI has
not been reported previously. Our 48-year old subject was completelye-of-the-tiger sign. T2W=T2 weighted imaging, SE= spin echo.
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during the following two years. Therefore, the signiﬁcance of the identi-
ﬁed eye-of-the-tiger-sign is puzzling. In the absence of symptoms no di-
agnosis of NBIA or any other neurological disorder associated with the
sign can be made.
The T2 hypointensity of the globus pallidus in the eye-of-the-tiger
sign is considered to reﬂect increased iron deposition, primarily in the
form of ferritin [13]. Although (non-haem) iron accumulates throughout
the brain in normal ageing, several neurodegenerative diseases are asso-
ciated with errors in iron metabolism, transport and homeostasis [14],
resulting in excess of iron deposition in speciﬁc anatomic structures. In
PKAN2 type patients, the central T2 hyperintensity has been attributed
to gliosis, increasedwater content and neuronal loss with disintegration,
vacuolization, and cavitation [1].
Two options seem to remain to explain the abnormalMRIﬁndings in
our case. Either our case has no disorder yet, or the ﬁnding of an eye-of-
the-tiger sign does not reﬂect the clinical status of our subject. The dis-
orders associated with the eye-of-the-tiger-sign usually presents in
early life, which would make this a (still to present clinically) very
late onset of NBIA, and from the ﬁve possibilities on the genetic basis,
only neuroferritinopathy would be a possible suspect, with a mean
age of onset reported of 39.4 years and a range of 13–63 years [5]. The
somewhat lower ferritin levels could support this notion, although fer-
ritin levels are only known for symptomatic patients and even then
these levels can be normal [5]. The other possible suspects of MSA-P,
PSP and CBD are unlikely, as the eye-of-the-tiger sign in itself is rare
in these disorders. It is unknown whether an eye-of-the-tiger-sign
could exist in these disorders when there are no overt symptoms. An-
other explanation for this case is the fact that there is always the possi-
bility of unknown genes. More genetic defects and also more subtypes
are being discovered. However until this date no subtype seems to
match the age criteria in this case other than the above named subtype.
Iron in healthy ageing is known to accumulate in subcortical grey mat-
ter structures, particularly in the globus pallidus [15], however the de-
velopment of an eye-of-the-tiger sign with the typical central zone of
T2 hyperintensity is not related to this natural process.
In conclusion, this case report demonstrates that the eye-of-the-
tiger sign can be found in healthy adults. It still holds true that thisradiologic ﬁnding is most commonly found in NBIA type 1, however
the ‘pathognomonic feature’ can be discussed.
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